» Authors » L Paracchini

L Paracchini

Explore the profile of L Paracchini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pellegrino B, Capoluongo E, Bagnoli M, Arenare L, Califano D, Scambia G, et al.
ESMO Open . 2025 Jan; 10(1):104091. PMID: 39754985
Background: Ovarian cancer (OvC) constitutes significant management challenges primarily due to its late-stage diagnosis and the development of resistance to chemotherapy. The standard treatment regimen typically includes carboplatin and paclitaxel,...
2.
Inchingolo F, Paracchini L, De Angelis F, Cielo A, Orefici A, Spitaleri D, et al.
Oral Implantol (Rome) . 2017 Mar; 9(Suppl 1/2016 to N 4/2016):65-70. PMID: 28280534
Modern implantology is based on the use of endosseous dental implants and on the study of osseointegration processes. The loss of marginal bone around a dental implant can be caused...
3.
Mannarino L, Paracchini L, Craparotta I, Romano M, Marchini S, Gatta R, et al.
Pharmacogenomics J . 2016 Dec; 18(1):56-63. PMID: 27958379
This study was designed to investigate the mode of action of trabectedin in myelomonocytic leukemia cells by applying systems biology approaches to mine gene expression profiling data and pharmacological assessment...
4.
Calura E, Paracchini L, Fruscio R, DiFeo A, Ravaggi A, Peronne J, et al.
Ann Oncol . 2016 May; 27(8):1511-9. PMID: 27194815
Background: Clinical and pathological parameters of patients with epithelial ovarian cancer (EOC) do not thoroughly predict patients' outcome. Despite the good outcome of stage I EOC compared with that of...
5.
Petrillo M, Zannoni G, Beltrame L, Martinelli E, DiFeo A, Paracchini L, et al.
Ann Oncol . 2016 Jan; 27(4):625-34. PMID: 26782955
Background: Neoadjuvant chemotherapy (NACT) has been recognized as a reliable therapeutic strategy in patients with unresectable advanced epithelial ovarian cancer (EOC). The molecular events leading to platinum (Pt) response in...
6.
Beltrame L, Di Marino M, Fruscio R, Calura E, Chapman B, Clivio L, et al.
Ann Oncol . 2015 Apr; 26(7):1363-71. PMID: 25846551
Background: The majority of patients with stage III-IV epithelial ovarian cancer (EOC) relapse after initially responding to platinum-based chemotherapy, and develop resistance. The genomic features involved in drug resistance are...
7.
Moritz N, Strandberg N, Zhao D, Mattila R, Paracchini L, Vallittu P, et al.
J Mech Behav Biomed Mater . 2014 Sep; 40:127-139. PMID: 25222871
Fiber-reinforced composites (FRC) could be feasible materials for fracture fixation devices if the mechanical properties of the composites are congruent with the local structural properties of bone. In a recently...
8.
Danza M, Quaranta A, Carinci F, Paracchini L, Pompa G, Vozza I
Minerva Stomatol . 2010 Jul; 59(6):305-13. PMID: 20588217
Aim: The aim of the present study was to analyze stress and strain distribution in dental implants with different abutment's inclination inserted in D1 and D4 bone. Methods: The biomechanical...
9.
Levrini L, Merlo P, Paracchini L
Eur J Paediatr Dent . 2008 Jan; 8(4):173-8. PMID: 18163851
Aim: This study was carried out with the purpose to show on a virtual model of oral cavity the mechanical behaviour of different kinds of pacifiers with different pressure levels...
10.
Bradamante S, MARCHESANI A, Barenghi L, Paracchini L, de Jonge R, de Jong J
Biochim Biophys Acta . 2000 Nov; 1502(3):363-79. PMID: 11068179
Using (13)C NMR, we tested the hypothesis that protection by preconditioning is associated with reduced glycogenolysis during ischemia. Preconditioned rat hearts showed improved postischemic function and reduced ischemic damage relative...